Novartis (NVS) Operating Margin (2006 - 2026)
Novartis (NVS) operating margin from Mar 31, 2006 to Mar 31, 2026. The current Novartis (NVS) operating margin is 31.31%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Operating Margin
Quarterly Operating Margin
Annual Operating Margin change of Novartis (NVS)
| Year | Operating Margin | Change |
|---|---|---|
| 2025 | 31.15% | +10.78% |
| 2024 | 28.12% | +34.31% |
| 2023 | 20.94% | +14.51% |
| 2022 | 18.28% | -20.05% |
| 2021 | 22.87% | +12.40% |
| 2020 | 20.35% | +9.00% |
| 2019 | 18.67% | +2.40% |
| 2018 | 18.23% | -9.08% |
| 2017 | 20.05% | +19.88% |
| 2016 | 16.72% | -6.13% |
| 2015 | 17.82% | -13.83% |
| 2014 | 20.68% | -0.76% |
| 2013 | 20.83% | -5.90% |
| 2012 | 22.14% | +21.95% |
| 2011 | 18.16% | -18.78% |
| 2010 | 22.35% | +1.01% |
| 2009 | 22.13% | +5.14% |
| 2008 | 21.05% | +20.90% |
| 2007 | 17.41% | -20.02% |
| 2006 | 21.77% | N/A |
Comparison Novartis (NVS) operating margin with competitors
Novartis (NVS) operating margin is 31.31%.
| Ticker | Name | Operating Margin | Upside |
|---|---|---|---|
| GILD | Gilead Sciences Inc | 37.16% | +18.67% |
| AMGN | AMGEN Inc | 30.94% | -1.20% |
| GSK | GSK Plc | 30.06% | -4.01% |
| AZN | Astrazeneca plc | 27.77% | -11.32% |
| ABBV | Abbvie Inc | 26.60% | -15.06% |
| JNJ | Johnson & Johnson | 26.58% | -15.12% |
| SNY | Sanofi | 20.18% | -35.56% |
| OGN | Organon & Company | 18.22% | -41.82% |
| GRFS | Grifols SA | 14.65% | -53.22% |